DNA plasmid vaccine for type 1 diabetes (Bayhill Therapeutics)

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameDNA plasmid vaccine for type 1 diabetes (Bayhill Therapeutics)
Drug Alias Name1型糖尿病DNA质粒疫苗 - Bayhill Therapeutics质粒DNA疫苗对1型糖尿病 - Bayhill TherapeuticsR-7426RG-7426BHT-3021 +[6] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGene transferenceImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayhill Therapeutics IncTolerion Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A